Low Caspase-8 levels are associated with a worse prognosis in patients with neuroblastoma [31,42,43], neuroendocrine lung tumors [44] and gynecological tumors, in which Caspase-8 loss promotes tumor aggressiveness and invasiveness [45]. This evidence concerns the gene CASP8 and lung neuroendocrine neoplasm.